Rogue Pharmacies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rogue Pharmacies
Government and private sector efforts take on counterfeit drugs online.


Pharmaceutical Technology
Volume 35, Issue 2, pp. 14


Alexis Pellek
How bad is the problem of illegal online pharmacies? One in six Americans has purchased a prescription drug online without a valid prescription, according to research presented by The Partnership at http://Drugfree.org/ during the White House Forum on Intellectual Property (IP) Theft in December 2010. That means 36 million Americans were at risk for buying counterfeit and substandard drugs from rogue pharmacy websites.

Speaking at the forum, US Attorney General Eric Holder noted examples of ways the Department of Justice is working to protect consumer health and safety, including the prosecution of counterfeit traffickers, the seizure of more than 80 websites selling counterfeit goods, and the use of new technologies and public-education campaigns. He called for more cooperation between government agencies, foreign regulators, and industry, saying, "The Internet remains a haven for illegal pharmacies and other operations that pose a danger to the American people, and we need a concerted, collaborative effort to put these illegal operations out of business."

A voluntary partnership made up of Google, Microsoft, and several other companies will target illegal online pharmacies and work to stop the sale of fake drugs. Along with American Express, eNom, GoDaddy, MasterCard, Neustar, Network Solutions, PayPal, Visa and Yahoo!, the companies agreed to form a nonprofit organization focused on fighting the spread of counterfeit drugs on the Internet by eradicating rogue pharmacies.

For a related story, see this month's Viewpoint column on illegal drug reimportation on p. 98.

Alexis Pellek is an assistant editor of Pharmaceutical Technology.

Read Alexis's blogs at http://blog.PharmTech.com/.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here